- Home
- YMAB vs BOOM Comparison
YMAB vs BOOM Comparison
Compare YMAB & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- BOOM
- Stock Information
- Founded
- YMAB 2015
- BOOM 1965
- Country
- YMAB United States
- BOOM United States
- Employees
- YMAB N/A
- BOOM N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- BOOM Industrial Specialties
- Sector
- YMAB Health Care
- BOOM Industrials
- Exchange
- YMAB Nasdaq
- BOOM Nasdaq
- Market Cap
- YMAB 192.4M
- BOOM 166.0M
- IPO Year
- YMAB 2018
- BOOM N/A
- Fundamental
- Price
- YMAB $4.36
- BOOM $8.59
- Analyst Decision
- YMAB Buy
- BOOM Buy
- Analyst Count
- YMAB 11
- BOOM 2
- Target Price
- YMAB $17.55
- BOOM $16.25
- AVG Volume (30 Days)
- YMAB 202.0K
- BOOM 163.7K
- Earning Date
- YMAB 08-11-2025
- BOOM 07-31-2025
- Dividend Yield
- YMAB N/A
- BOOM N/A
- EPS Growth
- YMAB N/A
- BOOM N/A
- EPS
- YMAB N/A
- BOOM N/A
- Revenue
- YMAB $88,658,000.00
- BOOM $635,272,000.00
- Revenue This Year
- YMAB N/A
- BOOM N/A
- Revenue Next Year
- YMAB $15.15
- BOOM $4.32
- P/E Ratio
- YMAB N/A
- BOOM N/A
- Revenue Growth
- YMAB 4.92
- BOOM N/A
- 52 Week Low
- YMAB $3.55
- BOOM $6.02
- 52 Week High
- YMAB $16.11
- BOOM $15.14
- Technical
- Relative Strength Index (RSI)
- YMAB 45.29
- BOOM 60.46
- Support Level
- YMAB $4.10
- BOOM $8.31
- Resistance Level
- YMAB $4.62
- BOOM $8.83
- Average True Range (ATR)
- YMAB 0.29
- BOOM 0.47
- MACD
- YMAB -0.04
- BOOM 0.02
- Stochastic Oscillator
- YMAB 20.73
- BOOM 75.60
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About BOOM DMC Global Inc.
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.